UBS AG analyst Charles Eden conducted a detailed study of the Symrise paper.
The major Swiss bank UBS has left the rating for Symrise at “Buy” with a price target of 99 euros. The growth outlook for 2026 is a bit poor, wrote Charles Eden on Wednesday. However, the margin targets of the manufacturer of fragrances and flavorings are higher.
Stock analysis online: The Symrise share under the microscope of current analyzes and valuations
The Symrise stock was in decline at 11:38 a.m. and had lost 1.4 percent to EUR 72.14 in XETRA trading. In this respect, the share still has room for improvement: 37.23 percent compared to the stated price target. Most recently, 165,168 Symrise shares were traded via XETRA. The share price has climbed 4.7 percent since the beginning of 2026. Symrise is expected to present its quarterly results for Q4 2025 on March 4, 2026.
ZURICH (dpa-AFX Analyzer) / editorial team finanzen.net
Original study published: March 4, 2026 / 07:37 / GMT
First distribution of the original study: March 4, 2026 / 07:37 / GMT
Note: Information on the disclosure obligation in the event of conflicts of interest within the meaning of Section 85 Para. 1 WpHG, Art. 20 Regulation (EU) 596/2014 for the analyst firm mentioned can be found at http://web.dpa-afx.de/offenlegenspflicht/offenlegens_pflicht.html.
Selected leverage products on Symrise
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Symrise
The leverage must be between 2 and 20
Advertising
